Pictet Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Sell
40,144
-5,619
-12% -$67.2K ﹤0.01% 1460
2026
Q1
$274K Buy
45,763
+6,907
+18% +$52K ﹤0.01% 1763
2025
Q4
$279K Hold
38,856
﹤0.01% 1747
2025
Q3
$415K Hold
38,856
﹤0.01% 1482
2025
Q2
$376K Sell
38,856
-11,585
-23% -$119K ﹤0.01% 1513
2025
Q1
$751K Sell
50,441
-1,907
-4% -$29.3K ﹤0.01% 1178
2024
Q4
$781K Buy
52,348
+2,861
+6% +$46.6K ﹤0.01% 1197
2024
Q3
$947K Buy
49,487
+6,264
+14% +$130K ﹤0.01% 1066
2024
Q2
$895K Sell
43,223
-9,251
-18% -$184K ﹤0.01% 1037
2024
Q1
$986K Sell
52,474
-4,123
-7% -$70.8K ﹤0.01% 1030
2023
Q4
$816K Sell
56,597
-14,976
-21% -$204K ﹤0.01% 1059
2023
Q3
$1.24M Buy
+71,573
New +$1.49M ﹤0.01% 943

Other funds holding OGN

Pictet Asset Management's OGN Position: Q2 2026 in Review

Pictet Asset Management reduced its Organon & Co (OGN) stake by 12% in Q2 2026, selling an estimated $67.2K and leaving 40,144 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Pictet Asset Management first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.24M in Q3 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Pictet Asset Management held 40,144 shares of Organon & Co worth $544K as of Q2 2026.
  • Pictet Asset Management sold 5,619 Organon & Co shares in Q2 2026, an estimated $67.2K.
  • Organon & Co made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1460 holding.
  • Pictet Asset Management first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Organon & Co position peaked at $1.24M in Q3 2023.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.